Q3 2018 EPS Estimates for Henry Schein, Inc. (HSIC) Reduced by Analyst
Henry Schein, Inc. (NASDAQ:HSIC) – Stock analysts at Barrington Research lowered their Q3 2018 earnings per share estimates for Henry Schein in a research note issued to investors on Tuesday, August 7th. Barrington Research analyst M. Petusky now forecasts that the company will post earnings of $0.97 per share for the quarter, down from their previous forecast of $0.98. Barrington Research currently has a “Buy” rating and a $92.00 price target on the stock. Barrington Research also issued estimates for Henry Schein’s FY2018 earnings at $4.10 EPS, Q1 2019 earnings at $0.93 EPS, Q2 2019 earnings at $1.10 EPS, Q3 2019 earnings at $1.15 EPS, Q4 2019 earnings at $1.22 EPS and FY2020 earnings at $4.78 EPS.
HSIC has been the subject of several other reports. BidaskClub cut shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Friday, July 13th. Zacks Investment Research raised shares of Henry Schein from a “hold” rating to a “buy” rating and set a $85.00 price target for the company in a report on Tuesday, July 10th. Goldman Sachs Group cut shares of Henry Schein from a “buy” rating to a “neutral” rating in a report on Tuesday, April 24th. Leerink Swann set a $100.00 price target on shares of Henry Schein and gave the stock a “buy” rating in a report on Tuesday, August 7th. Finally, Deutsche Bank increased their price target on shares of Henry Schein from $79.00 to $82.00 and gave the stock a “buy” rating in a report on Tuesday, April 24th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and nine have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $84.11.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Monday, August 6th. The company reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.01 by $0.03. The firm had revenue of $3.33 billion during the quarter, compared to analysts’ expectations of $3.31 billion. Henry Schein had a net margin of 3.15% and a return on equity of 20.40%. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.88 earnings per share.
In other Henry Schein news, EVP Mark E. Mlotek sold 10,359 shares of the stock in a transaction dated Tuesday, June 12th. The shares were sold at an average price of $72.73, for a total value of $753,410.07. Following the completion of the transaction, the executive vice president now directly owns 79,506 shares of the company’s stock, valued at $5,782,471.38. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Paul Brons sold 4,822 shares of the stock in a transaction dated Monday, June 11th. The shares were sold at an average price of $72.93, for a total transaction of $351,668.46. Following the completion of the transaction, the director now directly owns 20,889 shares of the company’s stock, valued at $1,523,434.77. The disclosure for this sale can be found here. Company insiders own 1.15% of the company’s stock.
Hedge funds have recently added to or reduced their stakes in the company. Squar Milner Financial Services LLC acquired a new stake in shares of Henry Schein in the second quarter valued at approximately $120,000. Piedmont Investment Advisors LLC acquired a new stake in shares of Henry Schein in the second quarter valued at approximately $130,000. Fuller & Thaler Asset Management Inc. grew its position in shares of Henry Schein by 57.1% in the second quarter. Fuller & Thaler Asset Management Inc. now owns 2,200 shares of the company’s stock valued at $160,000 after purchasing an additional 800 shares during the last quarter. BerganKDV Wealth Management LLC acquired a new stake in shares of Henry Schein in the second quarter valued at approximately $203,000. Finally, Quest Investment Management LLC acquired a new stake in shares of Henry Schein in the second quarter valued at approximately $214,000.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Article: New Google Finance Tool and Screening Stocks
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.